The invention concerns aryloxypropanolamine derivatives having at least an anti-diabetic
and anti-fat activity and their methods of preparation and applications, particularly
as human and veterinary medicine and animal food additive. These derivatives comply
with the general formula (I) in which R2 represents one of the following
groups: CH2, CH2CH2,
CH(CH3)CH2, C(CH3)CH,
C(CH3)2CH2 or a bond;
Q represents: (i) a phenyl radical 3,4-disubstituted alkylene dioxy determining
with the phenyl radical, a non-substituted benzodioxane unit, a non-substituted
benzodioxol unit, or a 2-substituted benzodioxol unit, (ii) a phenyl radical 3
and/or 4-substituted, by a O(CH2)xCOOR5
group, (iii) a condensed polycyclic hydrocarbon comprising at least two condensed
cycles, (iv) a cyclic hydrocarbon system, optionally cross-linked, and constituting
a cycloalkane comprising 1, 2 or 3 cycles
##STR1##
